Experience in Phase I Trials and an Upcoming Phase II Study with uPA Inhibitors in Metastatic Breast Cancer

gan Goldstein, Lori J.
Cyhoeddwyd 2008

American Society for Clinical Oncology 40th Annual Meeting, New Orleans, LA, 5–8 June 2004: breast cancer highlights

gan Sundermeyer, Mark L, Goldstein, Lori J
Cyhoeddwyd 2004

Profile of abemaciclib and its potential in the treatment of breast cancer

gan Martin, James M, Goldstein, Lori J
Cyhoeddwyd yn Onco Targets Ther (2018)

Role of Capecitabine in Early Breast Cancer

gan Varshavsky-Yanovsky, Asya N., Goldstein, Lori J.
Cyhoeddwyd yn J Clin Oncol (2020)

Tumor infiltrating lymphocytes (TILs) improve prognosis in patients with triple negative breast cancer (TNBC)

gan Adams, Sylvia, Goldstein, Lori J, Sparano, Joseph A, Demaria, Sandra, Badve, Sunil S
Cyhoeddwyd yn Oncoimmunology (2015)

TOP2A RNA Expression and Recurrence in Estrogen Receptor-Positive Breast Cancer

gan Sparano, Joseph A., Goldstein, Lori J., Davidson, Nancy E., Sledge, George W., Gray, Robert
Cyhoeddwyd yn Breast Cancer Res Treat (2012)

CSI: Cancer Signature Investigation: ERBB2 (HER2)-Activating Mutation and Amplification-Positive Breast Carcinoma Mimicking Lung Primary

gan Shih, Jennifer, Bashir, Babar, Gustafson, Karen S., Andrake, Mark, Dunbrack, Roland L., Goldstein, Lori J., Boumber, Yanis
Cyhoeddwyd yn J Natl Compr Canc Netw (2015)

Efficacy of eribulin for metastatic breast cancer based on localization of specific secondary metastases: a post hoc analysis

gan O’Shaughnessy, Joyce, Cortes, Javier, Twelves, Chris, Goldstein, Lori J., Alexis, Karenza, Xie, Ran, Barrios, Carlos, Ueno, Takayuki
Cyhoeddwyd yn Sci Rep (2020)

Identifying Patients Who May Be Candidates for a Clinical Trial of Salvage Accelerated Partial Breast Irradiation after Previous Whole Breast Irradiation

gan Li, Linna, Li, Tianyu, Cohen, Randi J., Anderson, Penny R., Goldstein, Lori J., Bleicher, Richard J., Freedman, Gary M.
Cyhoeddwyd 2012

Concurrent Doxorubicin Plus Docetaxel Is Not More Effective Than Concurrent Doxorubicin Plus Cyclophosphamide in Operable Breast Cancer With 0 to 3 Positive Axillary Nodes: North A...

gan Goldstein, Lori J., O'Neill, Anne, Sparano, Joseph A., Perez, Edith A., Shulman, Lawrence N., Martino, Silvana, Davidson, Nancy E.
Cyhoeddwyd 2008

Patterns of Multidisciplinary Care in the Management of Non-metastatic Invasive Breast Cancer in the United States Medicare Patient

gan Churilla, Thomas M., Egleston, Brian L., Murphy, Colin T., Sigurdson, Elin R., Hayes, Shelly B., Goldstein, Lori J., Bleicher, Richard J.
Cyhoeddwyd yn Breast Cancer Res Treat (2016)

Skin Involvement and Breast Cancer: Are T4B Lesions of All Sizes Created Equal?

gan Silverman, Diana, Ruth, Karen, Sigurdson, Elin R., Egleston, Brian L., Goldstein, Lori J., Wong, Yu-Ning, Boraas, Marcia, Bleicher, Richard J.
Cyhoeddwyd 2014

Phase Ib pilot study to evaluate reparixin in combination with weekly paclitaxel in patients with HER-2 negative metastatic breast cancer (MBC)

gan Schott, Anne F., Goldstein, Lori J., Cristofanilli, Massimo, Ruffini, Pier Adelchi, McCanna, Susan, Reuben, James M., Perez, Raymond P., Kato, Giraldo, Wicha, Max
Cyhoeddwyd yn Clin Cancer Res (2017)

Impact of the radiation boost on outcomes after breast-conserving surgery and radiation

gan Murphy, Colin, Anderson, Penny R, Li, Tianyu, Bleicher, Richard J, Sigurdson, Elin R, Goldstein, Lori J, Swaby, Ramona, Denlinger, Crystal, Dushkin, Holly, Nicolaou, Nicos, Freedman, Gary M
Cyhoeddwyd 2010

Risk of positive non-sentinel nodes in women with 1–2 positive sentinel nodes related to age and molecular subtype approximated by receptor status

gan Freedman, Gary M, Fowble, Barbara L., Li, Tianyu, Hwang, E. Shelley, Schechter, Naomi, Devarajan, Karthik, Anderson, Penny R, Sigurdson, Elin R., Goldstein, Lori J., Bleicher, Richard J.
Cyhoeddwyd yn Breast J (2014)

Towards an immunoscore for triple negative breast cancer (TNBC): lymphocytic infiltrate predicts outcome

gan Adams, Sylvia, Gray, Robert, Demaria, Sandra, Goldstein, Lori J, Perez, Edith A, Shulman, Lawrence N, Martino, Silvana, Davidson, Nancy E, Sledge, George W, Sparano, Joseph A, Badve, Sunil
Cyhoeddwyd 2013

Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer

gan Berry, Donald A., Cirrincione, Constance, Henderson, I. Craig, Citron, Marc L., Budman, Daniel R., Goldstein, Lori J., Martino, Silvana, Perez, Edith A., Muss, Hyman B., Norton, Larry, Hudis, Clifford, Winer, Eric P.
Cyhoeddwyd 2006

A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer

gan Goldstein, Lori J., Perez, Raymond P., Yardley, Denise, Han, Linda K., Reuben, James M., Gao, Hui, McCanna, Susan, Butler, Beth, Ruffini, Pier Adelchi, Liu, Yi, Rosato, Roberto R., Chang, Jenny C.
Cyhoeddwyd yn Breast Cancer Res (2020)

Correction to: A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer

gan Goldstein, Lori J., Perez, Raymond P., Yardley, Denise, Han, Linda K., Reuben, James M., Gao, Hui, McCanna, Susan, Butler, Beth, Ruffini, Pier Adelchi, Liu, Yi, Rosato, Roberto R., Chang, Jenny C.
Cyhoeddwyd yn Breast Cancer Res (2020)

Five-year Local Control on a Phase II Study of Hypofractionated Intensity Modulated Radiation Therapy with an Incorporated Boost for Early Stage Breast Cancer

gan Freedman, Gary M, Anderson, Penny R, Bleicher, Richard J., Litwin, Samuel, Li, Tianyu, Swaby, Ramona F, Ma, Chang-Ming Charlie, Li, Jinsheng, Sigurdson, Elin R, Watkins-Bruner, Deborah, Morrow, Monica, Goldstein, Lori J
Cyhoeddwyd 2012